Douglas Lane & Associates, LLC Merck & Co., Inc. Transaction History
Douglas Lane & Associates, LLC
- $6.9 Billion
- Q3 2025
A detailed history of Douglas Lane & Associates, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Douglas Lane & Associates, LLC holds 539,350 shares of MRK stock, worth $50.1 Million. This represents 0.66% of its overall portfolio holdings.
Number of Shares
539,350
Previous 519,901
3.74%
Holding current value
$50.1 Million
Previous $41.2 Million
9.99%
% of portfolio
0.66%
Previous 0.61%
Shares
34 transactions
Others Institutions Holding MRK
# of Institutions
3,977Shares Held
1.91BCall Options Held
29.9MPut Options Held
27.3M-
Vanguard Group Inc Valley Forge, PA254MShares$23.6 Billion0.36% of portfolio
-
Black Rock Inc. New York, NY207MShares$19.2 Billion0.59% of portfolio
-
State Street Corp Boston, MA118MShares$11 Billion0.35% of portfolio
-
Wellington Management Group LLP Boston, MA75.3MShares$6.99 Billion1.16% of portfolio
-
Geode Capital Management, LLC Boston, MA59.8MShares$5.55 Billion0.33% of portfolio
About Merck & Co., Inc.
- Ticker MRK
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,533,280,000
- Market Cap $235B
- Description
- Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...